Phase II trial of neoadjuvant cisplatin-fluorouracil chemotherapy surgery and intraperitoneal (IP) floxuridine (FUdR) plus leucovorin in patients with gastric cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Floxuridine; Fluorouracil; Folinic acid
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 03 Jul 2013 Biomarkers information updated
- 03 Feb 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual end date (Jan 2001) added as reported by ClinicalTrials.gov.